News

Verywell Health on MSN10d
Dupixent: The First FDA-Approved Biologic Drug to Treat Uncontrolled COPD
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
Hosted on MSN7mon
FDA Approves Dupixent Injections For People Struggling With COPD Symptoms
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive pulmonary disease (COPD) who continue to struggle ...
Becker's Hospital Review19d
FDA approves Dupixent as first chronic spontaneous urticaria therapy in over a decade
The condition is linked to Type 2 inflammation, which Dupixent helps target by blocking certain immune signaling pathways. The injection is already approved for CSU in several other countries ...
Monthly Prescribing Reference22d
Dupixent Approved for Chronic Spontaneous Urticaria
The most common adverse reaction reported with dupilumab in all 3 CUPID trials were injection site reactions. “Dupixent is the first new targeted treatment for chronic spontaneous urticaria ...
Morningstar22d
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Dupixent is an injection administered under the skin ... professional and can be given in a clinic or at home after training by a healthcare professional. In adolescents aged 12 to 17 years ...
KTBS17d
FDA Approves Dupixent for Chronic Spontaneous Urticaria
WEDNESDAY, April 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the ...
Yahoo Finance21d
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
“Dupixent is the first new targeted treatment for chronic spontaneous urticaria, or CSU, in over ten years, with pivotal trials demonstrating its ability to help patients significantly reduce ...